切换至 "中华医学电子期刊资源库"

中华胸部外科电子杂志 ›› 2014, Vol. 01 ›› Issue (01) : 48 -52. doi: 10.3877/cma.j.issn.2095-8773.2014.01.0010

所属专题: 文献

论著

食管鳞癌组织中miR-148a的表达及其临床意义
李树海1, 田辉1,(), 岳韦名1, 李林1, 高存1, 司立博1, 胡文思1, 亓磊1, 鲁铭1, 崔京京1, 陈观卿1   
  1. 1. 250012 济南,山东大学齐鲁医院胸外科
  • 收稿日期:2014-08-24 出版日期:2014-11-28
  • 通信作者: 田辉
  • 基金资助:
    山东大学自主创新基金(2012DX005); 国家自然科学基金(81301832)

Clinical significance of miR-148a expression in patients with esophageal squamous cell cancer

Shuhai Li1, Hui Tian1,(), Weiming Yue1, Lin Li1, Cun Gao1, Libo Si1, Wensi Hu1, Lei Qi1, Ming Lu1, Jingjing Cui1, Guanqing Chen1   

  1. 1. Department of Thoracic Surgery, Qilu Hospital, Shandong University, Jinan 250012, China
  • Received:2014-08-24 Published:2014-11-28
  • Corresponding author: Hui Tian
  • About author:
    Corresponding author: Tian Hui, Email:
引用本文:

李树海, 田辉, 岳韦名, 李林, 高存, 司立博, 胡文思, 亓磊, 鲁铭, 崔京京, 陈观卿. 食管鳞癌组织中miR-148a的表达及其临床意义[J]. 中华胸部外科电子杂志, 2014, 01(01): 48-52.

Shuhai Li, Hui Tian, Weiming Yue, Lin Li, Cun Gao, Libo Si, Wensi Hu, Lei Qi, Ming Lu, Jingjing Cui, Guanqing Chen. Clinical significance of miR-148a expression in patients with esophageal squamous cell cancer[J]. Chinese Journal of Thoracic Surgery(Electronic Edition), 2014, 01(01): 48-52.

目的

检测食管鳞癌组织中miR-148a的表达水平,探讨miR-148a表达与患者临床病理指标及预后的相关性。

方法

收集2009年1至12月在山东大学齐鲁医院胸外科行食管癌切除加系统性淋巴结清扫的75例食管鳞癌患者的肿瘤组织标本,采用实时荧光定量PCR法检测miR-148a的表达。应用SPSS 18.0软件建立数据库并进行统计分析。χ2检验分析miR-148a表达与患者临床病理指标之间的关系;Kaplan-Meier法绘制患者的生存曲线,Log-rank检验比较患者的生存差别,Cox回归多因素分析判定独立的预后因素。

结果

有32例患者肿瘤组织中miR-148a为低表达,miR-148a的低表达率为42.7%(32/75),与肿瘤浸润深度(χ2=8.149,P=0.017)、淋巴结转移(χ2=4.151,P=0.042)及病理分期(χ2=6.474,P=0.039)显著相关。患者术后3年的总生存率为70.7%。单因素生存分析结果显示,miR-148a低表达患者的术后3年总生存率显著低于miR-148a高表达患者(53.1%和83.7%,χ2=9.136,P=0.003)。Cox多因素回归分析结果显示,肿瘤浸润深度(95%CI为1.015~2.799,P=0.044)及淋巴结转移(95%CI为1.285~4.796,P=0.007)分别是判定患者术后3年总生存率的独立预后因素。

结论

miR-148a在食管鳞癌组织中存在异常低表达,并与肿瘤进展及患者的不良预后密切相关;miR-148a可作为预测食管鳞癌进展和判定患者不良预后的参考指标。

Objective

To detect the expression of miR-148a in the tissues of esophageal squamous cell cancer, and investigate its clinicopathological and prognostic significance.

Methods

The tumor tissue specimens of 75 patients with esophageal squamous cell cancer undergoing subtotal esophagectomy and regional lymph node dissection between January 2009 and December 2009 at Qilu Hospital, Shandong University were obtained. Real-time PCR was performed to detect the expression of miR-148a. All statistical analyses were done with SPSS 18.0 software. χ2 test was used to examine the association between miR-148a expression and clinicopathological factors. Survival curves were plotted by the Kaplan-Meier method, and survival differences were compared by the Log-rank test. Cox regression multivariate analysis was conducted to identify significantly independent prognostic factors.

Results

The low expression of miR-148a was detected in 32(42.7%, 32/75) cases, and significantly correlated with infiltration depth (χ2=8.149, P=0.017), lymph node metastasis (χ2=4.151, P=0.042) and pathological stage (χ2=6.474, P=0.039). The overall 3-year survival after operation was 70.7%, and univariate survival analysis demonstrated that patients with low expression of miR-148a had significantly lower 3-year overall survival than those with high expression of miR-148a (53.1% vs 83.7%, χ2=9.136, P=0.003). Cox regression multivariate survival analysis indicated that infiltration depth (95%CI: 1.015-2.799, P=0.044) and lymph node metastasis (95%CI: 1.285-4.796, P=0.007) were independent predictors for 3-year overall survival.

Conclusions

Aberrant low expression of miR-148a exists in tissues of esophageal squamous cell cancer, and is significantly associated with tumor progression and unfavorable prognosis. miR-148a may serve as an indicator of progression and poor prognosis of esophageal squamous cell cancer.

表1 miR-148a表达与食管癌患者临床病理指标之间的相关性
表2 食管癌患者术后单因素和多因素生存分析
图1 miR-148a低表达和高表达食管癌患者的术后3年总生存率
[1]
Sano A, Kato H, Sakurai S, et al. CD24 expression is a novel prognostic factor in esophageal squamous cell carcinoma[J]. Ann Surg Oncol, 2009,16(2):506-514.
[2]
Ren Y, Cao B, Law S, et al. Hepatocyte growth factor promotes cancer cell migration and angiogenic factors expression: a prognostic marker of human esophageal squamous cell carcinomas[J]. Clin Cancer Res, 2005,11(17):6190-6197.
[3]
Mariette C, Balon JM, Piessen G, et al. Pattern of recurrence following complete resection of esophageal carcinoma and factors predictive of recurrent disease[J]. Cancer, 2003,97(7):1616-1623.
[4]
Law S, Kwong DL, Kwok KF, et al. Improvement in treatment results and long-term survival of patients with esophageal cancer: impact of chemoradiation and change in treatment strategy[J]. Ann Surg, 2003,238(3):339-347.
[5]
Okawa T, Naomoto Y, Nobuhisa T, et al. Heparanase is involved in angiogenesis in esophageal cancer through induction of cyclooxygenase-2[J]. Clin Cancer Res, 2005;11(22):7995-8005.
[6]
Shih CH, Ozawa S, Ando N, et al. Vascular endothelial growth factor expression predicts outcome and lymph node metastasis in squamous cell carcinoma of the esophagus[J]. Clin Cancer Res, 2000;6(3):1161-1168.
[7]
Bartel DP. MicroRNAs: genomics, biogenesis, mechanism, and function[J]. Cell, 2004,116(2):281-297.
[8]
Lim LP, Lau NC, Garrett-Engele P, et al. Microarray analysis shows that some microRNAs down regulate large numbers of target mRNAs[J]. Nature, 2005,433(7027):769-773.
[9]
Dykxhoorn DM. MicroRNAs and metastasis: little RNAs go a long way[J]. Cancer Res, 2010,70(16):6401-6406.
[10]
Calin GA, Croce CM. MicroRNA signatures in human cancers[J]. Nat Rev Cancer, 2006,6(11):857-866.
[11]
Lovat F, Valeri N, Croce CM. Micro-RNAs in the pathogenesis of cancer[J]. Semin Oncol, 2011,38(6):724-733.
[12]
Chen PS, Su JL, Hung MC. Dysregulation of microRNAs in cancer[J]. J Biomed Sci, 2012,19:90.
[13]
贾筱琴,缪俊俊,雍军,等.miR-148a对肝癌细胞株侵袭和迁移的抑制作用及机制[J].中国癌症杂志,2014,24(6):412-417.
[14]
Chen Y, Song Y, Wang Z, et al. Altered expression of MiR-148a and MiR-152 in gastrointestinal cancers and its clinical significance[J]. J Gastrointest Surg, 2010,14(7):1170-1179.
[15]
Hummel R, Watson DI, Smith C, et al. Mir-148a improves response to chemotherapy in sensitive and resis-tant oesophageal adenocarcinoma and squamous cell carcinoma cells[J]. J Gastrointest Surg, 2011,15(3):429-438.
[16]
Zhang H, Li Y, Huang Q, et al. MiR-148a promotes apoptosis by targeting Bcl-2 in colorectal cancer[J]. Cell Death Differ, 2011,18(11):1702-1710.
[17]
Takahashi M, Cuatrecasas M, Balaguer F, et al. The clinical significance of MiR-148a as a predictive biomarker in patients with advanced colorectal cancer[J]. PLoS One, 2012,7(10):e46684.
[18]
Korst RJ, Rusch VW, Venkatraman E, et al. Proposed revision of the staging classification for esophageal cancer[J]. J Thorac Cardiovasc Surg, 1998;115(3):660- 669.
[19]
Hamilton SR, Aaltonen LA. Tumours of the digestive system[M]//Pathology and Genetics, World Health Organization Classification of Tumours. Lyon:IARC Press, 2000:10-25.
[20]
Greene FL, Page DL, Fleming ID, et al. AJCC cancer staging handbook[M]. 6th ed. New York: Springer-Verlag, 2002:91-98.
[21]
Fujita Y, Kojima K, Ohhashi R, et al. MiR-148a attenuates paclitaxel resistance of hormone-refractory, drug-resistant prostate cancer PC3 cells by regulating MSK1 expression[J]. J Biol Chem, 2010,285(25):19076-19084.
[22]
Murata T, Takayama K, Katayama S, et al. miR-148a is an androgen-responsive microRNA that promotes LNCaP prostate cell growth by repressing its target CAND1 expression[J]. Prostate Cancer Prostatic Dis, 2010,13(4):356-361.
[23]
邱光庭,王遂函,李大鹏,等.微小RNA-148a对胃癌细胞MKN45增殖能力的影响及机制研究[J].中华胃肠外科杂志,2014,17(10):1036-1039.
[24]
Bofill-De Ros X, Gironella M, Fillat C. miR-148a- and miR-216a-regulated oncolytic adenoviruses targeting pancreatic tumors attenuate tissue damage without perturbation of miRNA activity[J]. Mol Ther, 2014,22(9):1665-1677.
[25]
Tao S, He H, Chen Q, et al. GPER mediated estradiol reduces miR-148a to promote HLA-G expression in breast cancer[J]. Biochem Biophys Res Commun, 2014,451(1):74-78.
[26]
Zhou X, Zhao F, Wang ZN, et al. Altered expression of miR-152 and miR-148a in ovarian cancer is related to cell proliferation[J]. Oncol Rep, 2012,27(2):447-454.
No related articles found!
阅读次数
全文


摘要